Escherichia coli as a probiotic?
- 1 July 1998
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Infection
- Vol. 26 (4), 232-233
- https://doi.org/10.1007/bf02962369
Abstract
The influence of oral treatment with a suspension of non-pathogenicEscherichia coli cells (commercially available as: Symbioflor II®) on the morphological composition of the gut microflora and on the systemic humoral immune response (the IgG-, IgA-and IgM-isotype) against the bacterial cells in the Symbioflor II preparation was measured. After a pretreatment period of 21 days, ten healthy human volunteers ingested 1*108 cells ofE. coli daily for 14 days. Thereafter a follow-up period of 28 days completed the study. The results of this study indicated that no effect of the treatment on the composition of the gut microflora could be observed. However, the immune-fluorescence measurements revealed a significant increase in circulating amounts of IgG directed against the administeredE. coli cells. It is concluded that the treatment only resulted in a specific humoral immune response, while the gut microflora is not modulated.Keywords
This publication has 6 references indexed in Scilit:
- The story of live human intestinal bacteria administered orally as a remedyInfection, 1995
- Oral administration of a certain strain of liveEscherichia coli for intestinal disorders?Infection, 1995
- Computer processing of microscopic images of bacteria: morphometrY and fluorimetryTrends in Microbiology, 1994
- Statistical evaluation of an improved quantitative immunofluorescence method of measuring serum antibody levels directed against intestinal bacteriaJournal of Microbiological Methods, 1993
- Effects of ceftriaxone on faecal flora: analysis by micromorphometryEpidemiology and Infection, 1991
- [The treatment of intestinal diseases with Mutaflor. A multicenter retrospective study].1989